These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38966375)

  • 21. Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.
    Weber R; McCullagh M
    J Phys Chem B; 2021 Aug; 125(31):8787-8796. PubMed ID: 34328740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of nucleic acid unwinding by SARS-CoV helicase.
    Adedeji AO; Marchand B; Te Velthuis AJ; Snijder EJ; Weiss S; Eoff RL; Singh K; Sarafianos SG
    PLoS One; 2012; 7(5):e36521. PubMed ID: 22615777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase.
    Mirza MU; Froeyen M
    J Pharm Anal; 2020 Aug; 10(4):320-328. PubMed ID: 32346490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.
    Vivek-Ananth RP; Krishnaswamy S; Samal A
    Mol Divers; 2022 Feb; 26(1):429-442. PubMed ID: 34117992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex.
    Chen J; Zhou Y; Wei X; Xu X; Qin Z; Ong CP; Ye ZW; Jin DY; Boitrel B; Yuan S; Chan JF; Li H; Sun H
    ACS Infect Dis; 2024 Mar; 10(3):858-869. PubMed ID: 37897418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.
    Nandi R; Bhowmik D; Srivastava R; Prakash A; Kumar D
    J Biomol Struct Dyn; 2022; 40(22):12062-12074. PubMed ID: 34455933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling.
    Pitsillou E; Liang J; Hung A; Karagiannis TC
    J Mol Graph Model; 2022 Jul; 114():108193. PubMed ID: 35462185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
    Spratt AN; Gallazzi F; Quinn TP; Lorson CL; Sönnerborg A; Singh K
    Expert Opin Ther Pat; 2021 Apr; 31(4):339-350. PubMed ID: 33593200
    [No Abstract]   [Full Text] [Related]  

  • 30. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.
    White MA; Lin W; Cheng X
    J Phys Chem Lett; 2020 Nov; 11(21):9144-9151. PubMed ID: 33052685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors.
    El Hassab MA; Eldehna WM; Al-Rashood ST; Alharbi A; Eskandrani RO; Alkahtani HM; Elkaeed EB; Abou-Seri SM
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):563-572. PubMed ID: 35012384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Kuzikov M; Reinshagen J; Wycisk K; Corona A; Esposito F; Malune P; Manelfi C; Iaconis D; Beccari A; Tramontano E; Nowotny M; Windshügel B; Gribbon P; Zaliani A
    Virus Res; 2024 May; 343():199356. PubMed ID: 38490582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
    Newman JA; Douangamath A; Yadzani S; Yosaatmadja Y; Aimon A; Brandão-Neto J; Dunnett L; Gorrie-Stone T; Skyner R; Fearon D; Schapira M; von Delft F; Gileadi O
    Nat Commun; 2021 Aug; 12(1):4848. PubMed ID: 34381037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase.
    White MA; Lin W; Cheng X
    bioRxiv; 2020 Aug; ():. PubMed ID: 32817950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex.
    Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng E; Vatandaslar H; Chait BT; Kapoor T; Darst SA; Campbell EA
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
    Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SR; Aher A; Liu S; Kapoor TM
    bioRxiv; 2020 Jul; ():. PubMed ID: 32766580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
    Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng ET; Vatandaslar H; Chait BT; Kapoor TM; Darst SA; Campbell EA
    Cell; 2020 Sep; 182(6):1560-1573.e13. PubMed ID: 32783916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase.
    Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B
    Molecules; 2024 May; 29(10):. PubMed ID: 38792162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase.
    Ivanov KA; Thiel V; Dobbe JC; van der Meer Y; Snijder EJ; Ziebuhr J
    J Virol; 2004 Jun; 78(11):5619-32. PubMed ID: 15140959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca
    Yu J; Im H; Lee G
    Biochem Biophys Res Commun; 2023 Aug; 668():35-41. PubMed ID: 37235917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.